Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Journal of Clinical Microbiology|October 7, 2005
Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirusMelinda B Nye, Adam R Leman, Michelle E Meyer, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
A 46 XY phenotypic female adolescent with bilateral gonadal tumors consisting of five different componentsRochelle A Simon, Todd S Laughlin, Bonnie Nuccie, et al.Frontiers in Oncology|December 10, 2021
Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell LymphomasShenon Sethi, Zachary Epstein-Peterson, Anita Kumar, et al.Neuroscience Letters|August 10, 2005
Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotypeJennifer M Kwon, Paul G Rothberg, Adam R Leman, et al.Cancer Biomarkers : Section a of Disease Markers|December 24, 2010
Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancerManish Kohli, Paul G Rothberg, Changyong Feng, et al.Human Pathology|June 2, 2016
p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?Xi Wang, Moritz Stolla, Brian Z Ring, et al.The Journal of Molecular Diagnostics : JMD|June 17, 2008
Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemiaTodd S Laughlin, Michael W Becker, Jane L Liesveld, et al.Leukemia Research|October 26, 2005
Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experienceRoberto L Vargas, Enzo Fallone, Raymond E Felgar, et al.Human Pathology|April 26, 2017
p53 alteration in morphologically normal/benign breast luminal cells in BRCA carriers with or without history of breast cancerXi Wang, Amber A El-Halaby, Hengwei Zhang, et al.British Journal of Haematology|June 19, 2015
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cellsAndrew G Evans, Paul G Rothberg, W Richard Burack, et al.Pageof 8